People · Operator
Named in public records as an officer, director or promoter · active 2013–2022 · Other Technology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| DiCE MOLECULES HOLDINGS, LLC | — | Other Technology | Series C | $158.8M | $1.3B | 2018 |
| Biolumic, Inc. | — | Other Technology | Series A | $13.7M | $176.5M | 2021 |
| DiCE Molecules Corp | — | Other | Seed | $2.9M | $53.9M | 2013 |
John Bedbrook at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Bedbrook on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kevin Judice | 2 | 3 |
| Pehr Harbury | 2 | 2 |
| Mark Brown | 1 | 10 |
| Michael Rubin | 1 | 8 |
| Jake Simson | 1 | 6 |
| Richard Scheller | 1 | 4 |
| Sharon Tetlow | 1 | 4 |
| Steven Sibulkin | 1 | 4 |
| Shaan Gandhi | 1 | 4 |
| Scott Robertson | 1 | 3 |
| Richard Perry | 1 | 3 |
| Dean Tilyard | 1 | 2 |
| Adrian Percy | 1 | 2 |
| Michael Rabson | 1 | 2 |
| Stephen Zachary | 1 | 2 |
| Jim Scopa | 1 | 2 |
| Jason Wargent | 1 | 1 |
| Phil Patten | 1 | 1 |
| Phillip Patten | 1 | 1 |
| Mary Dimou | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.